EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Fibroblast Transcriptomics in Molecular Diagnostics of a Comprehensive Dystonia Cohort

Alice Saparov, Ivana Dzinovic, Theresa Brunet, Vicente A. Yépez, Florian Hölzlwimmer, Elisabetta Indelicato, Birgit Assmann, Susann Badmann, Diana Ballhausen, Steffen Berweck, Felix Brechtmann, Melanie Brugger, Kevork Derderian, Felix Distelmaier, Philip Harrer, Denisa Harvanova, Petra Havrankova, Ann‐Kathrin Jaroszynski, Miriam Kolnikova, Robert Kopajtich, Anne Koy, Magdalena Krygier, Lukas Kunc, Katarina Kusikova, Oliver Maier, Maria Mazurkiewicz‐Bełdzińska, Christian Mertes, Ava Oberlack, Timo Roser, Alexandra Sitzberger, Ugo Sorrentino, Antonia M. Stehr, Katharina Vill, Matias Wagner, Holger Prokisch, Sylvia Boesch, Jan Necpal, Robert Jech, Juliane Winkelmann, Elisabeth Graf

Annals of Neurology · 2026-06 · 99 (6) · 1363-1378

DOI: 10.1002/ana.78171 ↗
AbstractBibliografische Angaben

Abstract

Objective Genomic sequencing leaves >50% of dystonia‐affected individuals without a diagnosis. Where DNA‐oriented approaches remain insufficient, integrating multiomics is essential to advance genome interpretation. Herein, we incorporated RNA sequencing (RNA‐seq) data from 167 patients with dystonia across a range of ages and presentations. Methods We leveraged an RNA‐seq analysis pipeline, focused on the identification of expression and splicing aberrations, on RNA‐seq from skin biopsies. The recruited patients had early‐onset dystonia in 85.0%, non‐focal dystonia in 92.2%, and coexisting features in 76.0%. Thirty‐six patient samples with pre‐identified variants (36/167, 21.6%) and 131 samples with no previously prioritized diagnostic candidates from genomic sequencing (131/167, 78.4%) were evaluated. Results We found that >80% of dystonia‐associated genes were detected by fibroblast RNA‐seq. Expression and splicing aberration analyses produced a manageable number of significant RNA defects affecting dystonia‐associated genes. The approach was especially successful in validating pathogenic effects of loss‐of‐function variants, with disease‐relevant RNA‐underexpression detected for 66.7% (10/15). Studying aberrant expression and splicing in the context of other pre‐identified variant types yielded relevant results in 28.6% (6/21 samples). We obtained a 6.9% (9/131) diagnostic uplift for patients without prior candidates, all of whom exhibited combined dystonia with autosomal recessive inheritance. The new diagnoses from RNA‐seq and genomic reanalysis were based on previously neglected splice‐region (3/9) and deep(er) intronic (6/9) variants. For the observed events, integration of new machine‐learning scores predicted corresponding aberrant gene expression in the brain. Interpretation Fibroblast‐based RNA‐seq in our selected cohort improved variant interpretation and offered a modest yield in patients without prior candidate variants. ANN NEUROL 2026;99:1363–1378

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →